Singapore: ASLAN Pharmaceuticals has obtained the global rights to Almirall's DHODH inhibitor, LAS186323, currently in p...
Singapore: Professor Ian Frazer and his team at the University of Queensland, have been awarded grant from Australia's N...
According to the Global Burden of Disease and Risk Factors (World Bank Publications, 2006), infectious diseases are one ...
Singapore: The US Food and Drug Administration has issued a proposal designed to assist companies developing new treatme...
Singapore: India based drug company, Zydus, has initiated Phase III trials of Lipaglyn (Saroglitazar) to evaluate its sa...
Singapore: Melbourne-based biopharmaceutical company Specialised Therapeutics Australia (STA) has been granted exclusive...
Singapore: China-based 3SBio, which is focused on R&D, manufacturing and marketing biopharmaceutical products, acqu...
Singapore: Glenmark Pharmaceuticals, a research-driven, global integrated pharmaceutical company announced that its nove...
Singapore: US-based Avantor Performance Materials has introduced a higher purity Super Refined grade of polysorbate prod...
Singapore: Novartis Foundation for Sustainable Development (NFSD) has launched a new leprosy strategy focused on interru...
Singapore: AstraZeneca and NN Petrov Institute of Oncology, one of Russia's leading cancer research institutions, signed...
Singapore: A rapid heart rate is a common condition among elderly individuals, and represents a potential goldmine for p...
Singapore: Experimental Therapeutics Center (ETC) and Exploit Technologies of Agency for Science, Technology and Researc...
Singapore: The US Food and Drug Administration (FDA) has approved Stribild, a complete once-daily single tablet regimen ...
Singapore: Bionomics is going to present clinical trial data from its ongoing US trial of BNC105 in patients with metast...
Singapore: QRxPharma received complete response letter (CRL) regarding the company's Moxduo new drug application (NDA) f...
Singapore: 3SBio, China based biotechnology company, has signed license agreement with JenKem Technology to develop, man...
Singapore: Japanese firm Takeda Pharmaceutical has formed a research collaboration with the BC Cancer Agency to explore ...
Singapore: With the strategy to strengthen its pain management portfolio, global biopharmaceutical company, Teva Pharmac...
Singapore: The Japanese government has plans to help private-sector companies in exporting as early as 2015 regenerative...
Bayer HealthCare received approval in Japan for Gadovist (gadobutrol) injection for use with magnetic resonance imaging ...
Singapore: Australia-based GI Dynamics has conducted a new meta-analysis that demonstrates EndoBarrier Therapy, an endos...
Singapore: Data from the once-daily chronic obstructive pulmonary disease (COPD) clinical trial programs were presented ...
Singapore: The Korea Drug Development Fund (KDDF) has chosen PAREXEL International, a leading global biopharmaceutical s...
Singapore: Non-small cell lung cancer (NSCLC) therapeutics market value in the Asia-Pacific (APAC) region, Australia, Ch...
